Adjuvant pulse-dose-rate brachytherapy for oral cavity and oropharynx carcinoma: Outcome and toxicity assessment of 66 patients.

Fiche publication

Date publication

février 2024

Journal

Journal of contemporary brachytherapy

Auteurs

Membres identifiés du Cancéropôle Est :
Pr PEIFFERT Didier

Tous les auteurs :
Renard S, Demogeot N, Bruand M, Sahki N, Marchesi V, Gehin W, Meknaci E, Peiffert D

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/38584888

Résumé

Brachytherapy (BT) is a validated radiation technique for treatment of early stage tumors of oral cavity and oropharynx. This study aimed to analyze the results of our institute's patients after replacing low-dose-rate (LDR) with pulse-dose-rate (PDR) brachytherapy.